维普中文期刊产品整合服务
42篇 您的检索式:作者名="LoPiccolo"
    题名 作者 年代 出处 被引量
1Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations显示文摘LOPICCOLO J BLUMENTHAL G M BERNSTEIN W B 2008Drug Resist Updat2008,11,12:1
2Tarketing the P13K/Akt/mTOR pathway:effective combinations and clinical considerations显示文摘LOPICCOLO J BLUMENTHAL G M BEMSTEIN W B 2008Drug Resist Updat2008,11,:1
3Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations显示文摘LoPiccolo J Blumenthal GM Bernstein WB 2008Drug Resist Updat2008,11,12:1
4Targeting Akt in cancer therapy显示文摘LoPiccolo J Granville CA Gills JJ 2007Anticancer Drugs2007,18,86:1
5Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical con- siderations 显示文摘LoPiccolo J Blumenthal G M Bernstein W B 2008Drug resistance updates2008,1,2:1
6Targeting the PI3K/Akt/mTOR pathway: effective combi- nations and clinical considerations显示文摘LoPiccolo J 2008Drug Resist Updat2008,11,12:1
7Targeting Akt in cancer therapy 显示文摘LoPiccolo J Granville CA Gills J J 2007Anticancer Drugs2007,18,8:1
8Targeting the PI3K/Akt/mTOR pathway:effective combinations and clinical considerations显示文摘LoPiccolo J Blumenthal G M Bernstein W B 2008Drug Resist Updat2008,11,12:1
9PTEN hamartomatous tumor syndromes(PHTS) :rare syndromes with great relevance to common cancers and targeted drug development 显示文摘Lopiccolo J Ballas MS Dennis PA 2007Crit Rev Oncol Hematol2007,63,3:1
10Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical co- nsiderations显示文摘Lopiccolo J Blumenthal G M Bernstein W B 2008Drug Resistance Updates Reviews & Comment- aries in Antimicrobial & Anticancer Chemotherapy2008,,11:1
11Targeting the PI3K/Akt/mTOR pathway:effective combinations and clinical considerations显示文摘LoPiccolo J Blumenthal G M Bernstein W B Dennis P A 2008Drug Resist Updat2008,11,12:1
12Targeting thePI3 K/Akt/mTOR pathway : effective combinations and clinicalconsiderations显示文摘LoPiccolo J Blumenthal GM Bernstein WB 2008Drug Resist Updat2008,11,12:1
13Targeting the PI3K/Akt/mTOR pathway:Effective combinations and clinical considerations显示文摘LoPiccolo J Blumenthal GM Bernstein WB 2008Drug Resistance Updates2008,11,:1
14Clinical followup of couples Treated for sexual dysfunction显示文摘De Amicis LA Coldberg DC LoPiccolo J 1985Arch Sex Behav1985,14,6:1
15Targeting the PI3K/Akt/mTOR pathway: effective combinations and clini cal considerations显示文摘LoPiccolo J Blumenthal O M Bernstein W B etal 2008Drug Resist Updat2008,11,12:1
16Subcuticular incision versus naturally sourced porcine collagen filler for acne scars:A randomized split-face comparison显示文摘Sage RJ Lopiccolo Matteo C 2011Der-matologic Surgery2011,37,4:1
17Current issues in the diagnosis and management of malingering显示文摘Lopiccolo CJ Goodkin K Baldewicz TT 1999Am Med1999,31,:1
18Targe- ting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations 显示文摘LoPiccolo J Blumenthal GM Bernstein WB 2008Drug Resist Updat2008,11,12:1
19Targe-ting the PI3K/Akt/mTOR pathway:effective combinations and clinical considerations显示文摘LoPiccolo J Blumenthal GM Bernstein WB 2008Drug Resist Updat2008,11,12:1
20Synergistic effectsof nelfinavir and bortezomib on proteotoxic death ofNSCLC and multiple myeloma cells显示文摘Kawabata S?Gills J J Mercado-Matos J R Lopiccolo J Wilson W 3rd Hollander M C 2012Cell Death Dis2012,3,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费